Boston Scientific

Proven to Reduce NVAF Stroke Risk for Life

By Boston Scientific
By Boston Scientific
81 views
June 20, 2023
See how the WATCHMAN FLX Implant reduces troke risk while eliminating OAC bleed risk for NVAF patients.
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
03:37
Boston Scientific

WATCHMAN: The Referring Process

Feat. T. Diaz Balderrama, R. Shah
05:09
Boston Scientific

WATCHMAN: An Alternative to OACs

Feat. T. Diaz Balderrama, R. Shah
01:44
Boston Scientific

Patient outcomes after receiving the WATCHMAN Implant

Feat. T. Diaz Balderrama, T. Randle, R. Shah
01:27
Boston Scientific

Referring patients for the WATCHMAN Implant

Feat. T. Diaz Balderrama, T. Randle, R. Shah
02:18
Boston Scientific

Freedom from OACs

Feat. T. Diaz Balderrama, T. Randle, R. Shah
01:28
Boston Scientific

Protect your patients: Stroke risk reduction without the risks of OA…

Feat. T. Diaz Balderrama, T. Randle, R. Shah
01:27
Boston Scientific

Proven Clinical Outcomes

Feat. T. Diaz Balderrama, T. Randle, R. Shah
01:57
Boston Scientific

Identifying eligible patients for the WATCHMAN Implant

Feat. T. Diaz Balderrama, T. Randle, R. Shah
01:01
Boston Scientific

Designed to Protect More NVAF Patients from Stroke

01:01
Boston Scientific

Patient Screening & Criteria

04:24
Boston Scientific

Proven Stroke Protection Without Lifelong OAC Bleed Risk

31
Boston Scientific

Clinically Proven to Safely & Effectively Reduce NVAF Stroke Risk

31
Boston Scientific

Most Studied & Implanted LAAC Device

31
Boston Scientific

Proven Safety & Advanced Procedural Performance

31
Boston Scientific

Advancing Safety & Simplicity in LAAC - See the Difference

31
Boston Scientific

Clinically Proven Safe Outcomes - PINNACLE FLX Clinical Trial Data

31
Boston Scientific

Advancing Safety In LAAC

31
Boston Scientific

Designed to Protect a Broad Range of Patients

31
Boston Scientific

Patient Eligibility Criteria

25:21
Congenital and Structural Interventions

LAA Closure for Atrial Fibrillation using Occlusion Device

Feat. H. Sievert
31
Boston Scientific

Designed to Protect a Broad Range of Patients

31
Boston Scientific

Patient Eligibility Criteria

31
Boston Scientific

Clinically Proven to Safely & Effectively Reduce NVAF Stroke Risk

31
Boston Scientific

Advancing Safety & Simplicity in LAAC - See the Difference

31
Boston Scientific

Clinically Proven Safe Outcomes - PINNACLE FLX Clinical Trial Data

31
Boston Scientific

Most Studied & Implanted LAAC Device

31
Boston Scientific

Proven Safety & Advanced Procedural Performance

08:15
Georgia Heart Institute

Interview with Dr. Christopher Ellis: Left Atrial Appendage Manageme…

Feat. D. Weisman, C. Ellis
31
Boston Scientific

Advancing Safety In LAAC

18:26
Stanford Medicine

When Is LAA Closure Device an Option?

Feat. C. Liu
14:16
Penn Medicine Heart and Vascular Center

Stroke Prevention in Atrial Fibrillation

Feat. D. Goldberg
14:47
ACC 2023 Conference Coverage

ACC 2023: Can LAAC Be Considered a True Alternative to OAC?

Feat. A. Natale
14:23
The Texas Heart Institute

Atrial Fibrillation: New Treatments

Feat. J. Cozart
16:28
Piedmont Heart Institute Napa Valley Cardiology Conference

The Stroke Prevention War: DOAC vs Warfarin vs LAA Device Closure

Feat. T. Deering
08:49
University of Miami

A Revolutionary Approach to Left Atrial Appendage Closure - LAMINAR …

Feat. S. Kar
20:15
Cardiology Fiesta 2017

The Guidelines: Current Recommendations for TAVR, Left Atrial Append…

Feat. S. Bailey
15:52
ARCH Advanced Revascularization Symposium

LAA Closure: Patient Selection, Imaging and Anti-Thrombotic Therapy

Feat. S. Yakubov
20:30
Scripps 9th Annual Structural Heart Intervention and Imaging 2020: A Practical Approach

Transcatheter LAA Closure for Stroke Prevention: Current Data and Fu…

Feat. M. Price
23:00
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

What’s the Best Way to Manage Patients with Atrial Fibrillation?

Feat. J. Hsu